Covectra strengthens board of directors

Van den Hooff brings over 35 years of global operating experience in the healthcare industry, with specific expertise in consumer pharmaceuticals, medical devices and supplies/services for the pharmaceutical industry. He held various senior leadership positions, as CEO and board member of Temptime Corporation and as president and CEO of a public startup healthcare company that developed and sold innovative wound care products. 

He had a 20-year career with Johnson & Johnson, serving the latter time there as president of the J&J-Merck consumer pharmaceuticals joint venture worldwide. Van den Hoof has also been involved for almost 20 years with the National Multiple Sclerosis Foundation, where he has served on the board of trustees and chaired multiple strategic committees supporting the CEO.

Miloscia has over 22 years of experience in several management positions. He currently served as CFO for Covectra, where he is responsible for all strategic business and financial planning and analysis and marketing activities. Before joining Covectra, he held senior-level positions at Fidelity Investments, Health Dialog, and American Express. 

‘On behalf of the entire board of directors, it is a pleasure to welcome Renaat and Gary, two highly accomplished industry veterans, to our team,’ said Steve Wood, president, and chief executive officer of Covectra. ‘Their collective experience across a range of diverse strategic roles will be highly instrumental as we continue to advance our product development and build out our pipeline. I look forward to working with them and leveraging their unique expertise.’